Study shows significant drop in insulin costs after colorado caps prices

Diabetes affects millions of Americans, with 1.4 million new cases diagnosed each year. This chronic condition is one of the leading causes of death in the United States and accounts for more than $320 billion in annual health care costs.

UK MHRA extends licence for Vertex children’s cystic fibrosis drugs

Share this article Kaftrio and Kalydeco are now indicated for usage in children aged two to five years with cystic fibrosis. Credit: FAMILY STOCK /

November 16, 2023

Uveitis drugs in development, 2023

GlobalData tracks 85 drugs in development for Uveitis by 77 companies/universities/institutes. The top development phase for Uveitis is preclinical, with 51 drugs in that stage.

December 1, 2023

Ultra-processed foods raise chronic kidney disease risk, study shows

Consuming ultra-processed foods is linked to an 18% increased risk of chronic kidney disease, with every 10% rise in UPF intake energy contributing to a

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.